Showing results (11-20 of 199) with videos related to
Sort By:
Pageof 20
Frontiers in Oncology|March 30, 2018
A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?Quentin Haas, Cedric Simillion, Stephan von GuntenFrontiers in Physiology|February 24, 2017
The Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM)Thaleia Kouskoura, Christos Katsaros, Stephan von GuntenThe Journal of Allergy and Clinical Immunology|January 10, 2004
Verdict in the case of therapies versus eosinophils: the jury is still outBruce S BochnerImmunology and Allergy Clinics of North America|July 27, 2015
Novel Therapies for Eosinophilic DisordersBruce S BochnerImmunology and Allergy Clinics of North America|October 12, 2004
Adhesion molecules as therapeutic targetsBruce S BochnerGlycobiology|February 26, 2016
"Siglec"ting the allergic response for therapeutic targetingBruce S BochnerPharmacological Research|February 10, 2019
Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG)Stefanie Graeter, Hans-Uwe Simon, Stephan von GuntenArchivum Immunologiae Et Therapiae Experimentalis|September 18, 2016
Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin PreparationsPeter J Späth, Christoph Schneider, Stephan von GuntenSeminars in Hematology|May 14, 2013
Cell death in immune thrombocytopenia: novel insights and perspectivesStephan von Gunten, Marc Wehrli, Hans-Uwe SimonBiochemical Pharmacology|June 11, 2011
Targeting siglecs--a novel pharmacological strategy for immuno- and glycotherapyCamilla Jandus, Hans-Uwe Simon, Stephan von GuntenPageof 20